Clinical trial
Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
NCT00115375 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00115375 |
|---|---|
| Title | Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO) |
| Official title | Dose-Ranging Pharmacodynamic Assessment of Platelet Aggregation Inhibition With Clopidogrel in Children of Blalock-Taussig Shunt Age Categories (Neonates and Infants/Toddlers) |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Congenital Heart Defects, Blood Platelet Disorders |
| Intervention type | Drug |
| Interventions | Clopidogrel (SR25990) |
| Enrollment | 92 |
| Start date | Jan 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Jun 22, 2005 |
| Last update posted | Mar 25, 2009 |
| Countries | Belgium, Canada, France, Germany, Italy, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: